Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan D Berlin

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|November 9, 2013
Pancreas cancer on the rise: are we up to the challenge?Dana B Cardin, Jordan D Berlin
Cancer Investigation|February 9, 2008
A 17 year-old man with an exon 11 mutation of CD-117 causing a gastrointestinal stromal tumorTodd M Bauer, Jordan D Berlin
Pancreas|January 14, 2017
Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer?Ramya Thota, Anirban Maitra, Jordan D Berlin
Seminars in Oncology|February 24, 2005
The epidermal growth factor receptor as a target for colorectal cancer therapyA Craig Lockhart, Craig Lockhart, Jordan D Berlin
Oncology (Williston Park, N.Y.)|April 2, 2014
Treatment of metastatic pancreatic adenocarcinoma: a reviewRamya Thota, James M Pauff, Jordan D Berlin
Oncology (Williston Park, N.Y.)|April 5, 2011
Treatment of early-stage pancreatic cancerEmily H Castellanos, Dana B Cardin, Jordan D Berlin
Current Treatment Options in Oncology|September 3, 2004
The epidermal growth factor receptor as a target for gastrointestinal cancer therapyKaren L Tedesco, A Craig Lockhart, Jordan D Berlin
F1000Research|March 10, 2020
Recent advances in the treatment of pancreatic cancerMarc T Roth, Dana B Cardin, Jordan D Berlin
Surgical Oncology Clinics of North America|February 18, 2010
Update on adjuvant trials for pancreatic cancerDana C Backlund, Jordan D Berlin, Alexander A Parikh
Gastroenterology|May 12, 2005
Treatment for pancreatic cancer: current therapy and continued progressA Craig Lockhart, Mace L Rothenberg, Jordan D Berlin
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|November 9, 2013
Pancreas cancer on the rise: are we up to the challenge?Dana B Cardin, Jordan D Berlin
Cancer Investigation|February 9, 2008
A 17 year-old man with an exon 11 mutation of CD-117 causing a gastrointestinal stromal tumorTodd M Bauer, Jordan D Berlin
Pancreas|January 14, 2017
Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer?Ramya Thota, Anirban Maitra, Jordan D Berlin
Seminars in Oncology|February 24, 2005
The epidermal growth factor receptor as a target for colorectal cancer therapyA Craig Lockhart, Craig Lockhart, Jordan D Berlin
Oncology (Williston Park, N.Y.)|April 2, 2014
Treatment of metastatic pancreatic adenocarcinoma: a reviewRamya Thota, James M Pauff, Jordan D Berlin
Oncology (Williston Park, N.Y.)|April 5, 2011
Treatment of early-stage pancreatic cancerEmily H Castellanos, Dana B Cardin, Jordan D Berlin
Current Treatment Options in Oncology|September 3, 2004
The epidermal growth factor receptor as a target for gastrointestinal cancer therapyKaren L Tedesco, A Craig Lockhart, Jordan D Berlin
F1000Research|March 10, 2020
Recent advances in the treatment of pancreatic cancerMarc T Roth, Dana B Cardin, Jordan D Berlin
Surgical Oncology Clinics of North America|February 18, 2010
Update on adjuvant trials for pancreatic cancerDana C Backlund, Jordan D Berlin, Alexander A Parikh
Gastroenterology|May 12, 2005
Treatment for pancreatic cancer: current therapy and continued progressA Craig Lockhart, Mace L Rothenberg, Jordan D Berlin
Pageof 9